We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current AMRN market cap is 274.37M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 55.16M | 68.85M | 42.3M | 62.31M | 41.04M |
| Operating Income | -13.58M | -524k | -23.21M | -167.86M | -16.76M |
| Net Income | -9.95M | 1.52M | -25.13M | -48.62M | -15.7M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 614.06M | 583.19M | 369.19M | 306.91M | 228.61M |
| Operating Income | -19.66M | 10.5M | -105.87M | -67.59M | -91.8M |
| Net Income | -18M | 7.73M | -105.8M | -59.11M | -82.18M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 790.01M | 799.86M | 750.62M | 685.35M | 655.68M |
| Total Liabilities | 244.08M | 247.98M | 219.24M | 199.17M | 181.99M |
| Total Equity | 545.94M | 551.88M | 531.38M | 486.18M | 473.69M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 966.02M | 1.07B | 886.18M | 831.68M | 685.35M |
| Total Liabilities | 338.52M | 400.97M | 290.85M | 279.59M | 199.17M |
| Total Equity | 627.51M | 667.1M | 595.33M | 552.1M | 486.18M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -12.6M | -15.35M | -17.71M | -31.02M | -12.46M |
| Investing | 28.72M | 33.41M | -23.14M | -45.98M | 12.06M |
| Financing | -1.43M | -1.39M | -1.46M | -1.44M | -1.12M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -21.75M | -66.54M | -180.09M | 6.88M | -31.02M |
| Investing | -376.96M | 104.1M | 175.29M | -25.52M | -45.98M |
| Financing | -58.91M | -5.07M | -379k | 230k | -1.44M |
| Market Cap | 274.37M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 20.71M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.35 (2.61%) |
| Company Name | Amarin Corporation PLC |
| Address |
one new change london EC4M 9AF |
| Website | https://www.amarincorp.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
